Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT00580125

Femme et Homme

Extrait

The objective of this study is demonstrate efficacy and a dose-response in the treatment of acute exacerbation of schizophrenia in comparison to placebo.


Critère d'inclusion

  • Schizophrenia


Liens